Bliss Gvs Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 07-09-2024
- Paid Up Capital ₹ 10.50 Cr
as on 07-09-2024
- Company Age 40 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 239.00 Cr
as on 07-09-2024
- Satisfied Charges ₹ 301.25 Cr
as on 07-09-2024
- Revenue -1.56%
(FY 2024)
- Profit -40.75%
(FY 2024)
- Ebitda 18.87%
(FY 2024)
- Net Worth 5.49%
(FY 2024)
- Total Assets 1.13%
(FY 2024)
About Bliss Gvs Pharma
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506197 and on the National Stock Exchange(NSE) under BLISSGVS.
The Corporate was formerly known as Bliss Gvs Phrma Limited (Cn). The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 10.50 Cr.
The company currently has active open charges totaling ₹239.00 Cr. The company has closed loans amounting to ₹301.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Bliss Gvs Pharma Limited India are Ms Bhatt as COMPANY SECRETARY and Deepak Sawant as Cfo. Gagan Harsh, Shilpa Bhatia, Subramanian Vaidya, and Four other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bliss Gvs Pharma Limited offer?
Bliss Gvs Pharma Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pharmaceutical Injectables, Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Bliss Gvs Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gagan Harsh  | Managing Director | 21-Jan-2021 | Current |
| Ms Bhatt | Company Secretary | 09-Aug-2018 | Current |
| Deepak Sawant | CFO | 30-Dec-2022 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Parab | Director | 24-May-2016 | Current |
| Subramanian Vaidya | Director | 01-Aug-2011 | Current |
| Nandkumar Chodankar | Director | 05-Aug-2024 | Current |
| Shilpa Bhatia | Director | 11-Feb-2020 | Current |
| Vibha Sharma | Whole-Time Director | 29-Jul-2008 | Current |
| Shruti Rao | Whole-Time Director | 27-Jul-2006 | Current |
Financial Performance and Corporate Structure Insights of Bliss Gvs Pharma.
Bliss Gvs Pharma Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 1.56% decrease. The company also saw a substantial fall in profitability, with a 40.75% decrease in profit. The company's net worth moved up by a moderate rise of 5.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bliss Gvs Pharma?
In 2023, Bliss Gvs Pharma had a promoter holding of 35.04% and a public holding of 64.96%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asolution Pharmaceuticals Private LimitedActive 14 years 7 monthsNandkumar Chodankar is a mutual person
Kremoint Pharma Private LimitedActive 32 years 7 monthsGagan Harsh and Vibha Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Dec 2023 | ₹35.00 Cr | Open |
Others Creation Date: 02 Sep 2023 | ₹53.00 Cr | Open |
Others Creation Date: 17 Sep 2021 | ₹65.00 Cr | Open |
How Many Employees Work at Bliss Gvs Pharma?
Bliss Gvs Pharma has a workforce of 813 employees as of Sep 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bliss Gvs Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bliss Gvs Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
